Catherine Frenette
Gastroenterology · la Jolla, CANPI 1417935081
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $209,325 of the $342,325 with a category attached, or 61.1%. 27 manufacturers reported payments, led by Eisai Inc. at 24.9% of the total. Reporting peaked in 2019 at $184,800 and has fallen 100.0% since, to $56 in 2024. Among gastroenterology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 380 payments — averaging $900.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$85K
- Gilead$66K
- Exelixis Inc.$59K
- Bayer$37K
- Genentech USA, Inc.$21K
- E.r. Squibb & Sons, L.L.C.$21K
- plus $54K from 21 others
Across 113 payments — averaging $12,789 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$1.2M
- Merck$206K
- Exelixis Inc.$73K
- Dova Pharmaceuticals$13K
- Mallinckrodt Enterprises LLC$4K
What the payments were for
- Consulting fees$99,68029%
- Speaking & faculty fees$209,32561%
- Travel & lodging$25,5457%
- Food & beverage$7,7102%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 81 | $85,232 |
| Gilead | 78 | $65,889 |
| Exelixis Inc. | 54 | $58,538 |
| Bayer | 26 | $36,886 |
| Genentech USA, Inc. | 13 | $21,382 |
| E.r. Squibb & Sons, L.L.C. | 21 | $20,579 |
| AbbVie | 21 | $13,334 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $10,082 |
| Shionogi Inc | 14 | $9,376 |
| Intercept Pharmaceuticals, Inc. | 12 | $6,308 |
| Dova Pharmaceuticals | 2 | $3,861 |
| AstraZeneca | 1 | $2,700 |
| Astrazeneca UK Limited | 2 | $2,551 |
| Merck | 2 | $2,518 |
| Genentech, Inc. | 1 | $2,375 |
| Fujifilm Wako Diagnostics U.S.A. Corporation | 4 | $165 |
| Intuitive Surgical | 2 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $129 |
| Mallinckrodt Enterprises LLC | 1 | $73 |
| Aimmune Therapeutics, Inc. | 1 | $56 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Alfasigma USA, Inc. | 2 | $34 |
| QOL Medical, LLC | 2 | $23 |
| Dynavax Technologies Corporation | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Pentax Of America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$342,325 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.
Other gastroenterology in la Jolla
- Quan Nhula Jolla$641K
- Paul Pockrosla Jolla$318K
- Walter Coylela Jolla$269K
- Bennett RothLos Angeles$2.8M
- Douglas NguyenMission Viejo$2M
- Sammy SaabLos Angeles$1.9M
- Kenneth ChangNewport Beach$1.3M
- Joo HwangStanford$1M
- Drew SchembreWalnut Creek$659K
- Sadeea AbbasiLos Angeles$556K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.